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Aims: To investigate pathways through which momentary negative affect and 
depressive symptoms affect lapse risk. Design: Ecological Momentary Assessment was 
carried out during two weeks after an unassisted smoking cessation attempt. A three-month 
follow-up measured smoking frequency. Setting: Data were collected via mobile devices in 
German-speaking Switzerland. Participants: A total of 242 individuals (age 20-40, 67% 
men) reported 7,112 observations. Measurements: Online surveys assessed baseline 
depressive symptoms and nicotine dependence. Real-time data on negative affect, physical 
withdrawal symptoms, urge to smoke, abstinence-related self-efficacy, and lapses. Findings: 
Two-level structural equation model suggested that on the situational level, negative affect 
increased the urge to smoke and decreased self-efficacy ( = .20;  = -.12, respectively), but 
had no direct effect on lapse risk. A higher urge to smoke ( = .09) and lower self-efficacy ( 
= -.11) were confirmed as situational antecedents of lapses. Depressive symptoms at baseline 
were a strong predictor of a person’s average negative affect ( = .35, all p <.001). However, 
the baseline characteristics influenced smoking frequency three months later only indirectly, 
through influences of average states on the number of lapses during the quit attempt. 
Conclusions: Controlling for nicotine dependence, higher depressive symptoms at baseline 
were strongly associated with higher average negative affect during the smoking cessation 
attempt, which in turn were associated with a worse longer-term outcome. Negative affect 
experienced during the quit attempt was the only pathway through which the baseline 
depressive symptoms were associated with a reduced self-efficacy and increased urges to 
smoke, all leading to the increased probability of lapses. 
 




Recent and past depressive symptomatology is a robust predictor of poor smoking 
cessation outcomes [1-7]. Factors linking depression and relapse include higher levels of 
physical withdrawal symptoms [8,9],  a lower self-efficacy to refrain from smoking [10,11]  
or higher levels of cravings [9,12]. These factors are all established predictors of lapses and 
relapses on the state as well as the trait level [13-23]. Yet, to date, these predictors have not 
been integrated into a common framework and it is not well understood to what extent and 
through which pathways depressive symptoms affect proximal antecedents of lapses and 
increase the lapse risk.  
The cognitive-behavioural relapse model by Marlatt and Gordon [24-27] posits that 
momentary internal and external conditions such as negative affect, low self-efficacy, social 
pressure, or substance-related cues can create high-risk situations with a strong urge to smoke 
or even a lapse, defined as a one-time consumption of tobacco. Distal background variables 
on the person level such as personality traits or psychological distress are thought to influence 
momentary internal conditions in high-risk situations as well as how an individual deals with 
lapses and whether a lapse leads to the abandonment of the abstinence goal [24-27].   
The present study examined how momentary negative affect, physical withdrawal 
symptoms, the urge to smoke, and abstinence-related self-efficacy influenced subsequent 
lapse risk on the situational level. On the person level, we analysed how and to what extent 
depressive symptoms as more enduring characteristics of an individual influenced a person’s 
average situational states and the frequency of lapses during the first two weeks of an 
unassisted smoking cessation attempt. Furthermore, we investigated whether depressive 
symptoms at baseline would predict smoking frequency three months later. 
On the situational level, we first expected that negative affect would reduce abstinence-related 
self-efficacy, which in turn would render individuals more vulnerable for lapses 
[16,18,28,29]. Abstinence-related self-efficacy is the confidence that one is capable of 
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remaining abstinent and operates through cognitive, motivational, affective and decisional 
processes [30-34]. Self-efficacy is thought to foster motivation and perseverance in the face of 
high-risk situations. Negative affect as well a higher urge to smoke may challenge the belief 
of being able to remain abstinent and may thus reduce self-efficacy [24-27,34]. Second, we 
expected that negative affect as well as physical withdrawal symptoms would increase the 
urge to smoke [35]. This is in line with the negative reinforcement model of substance use 
[36], which assumes that addicted smokers use tobacco to escape or avoid negative affect or 
withdrawal symptoms. Higher urge levels in turn would increase lapse risk directly [17,23,37-
39] as well as through reducing self-efficacy. Frequent elevated urges to smoke are thought to 
deplete one’s self-control to resist smoking and can thus lead to smoking lapse [40-42]. Third, 
we tested whether negative affect would have an additional direct effect on lapse risk, for 
example as conditioned stimuli that elicit a conditioned response or by negative reinforcement 
[36]. The proposed model of interplay between momentary states and subsequent lapses at the 
situational level is illustrated in Figure 1 (top panel).  
Insert Figure 1 about here 
On the person-level, we tested whether the situational level pathways would be 
confirmed as more stable patterns of relationships between a person’s average states during 
the first two weeks of a quit attempt, and whether depressive symptoms and nicotine 
dependence at baseline predicted these average states.  Pervasive and persistent negative 
affect is a core symptom of depression [43]. Furthermore, depression-specific biases in 
information processing, such as a pessimistic explanatory style and increased elaboration of 
negative material can increase negative affect and decrease self-efficacy [44]. Thus, we 
expected that depressive symptoms would increase average negative affect during the 
smoking cessation attempt in addition to the effects of nicotine dependence and withdrawal 
symptoms. Furthermore, we assumed that baseline depressive symptoms would directly 
decrease average abstinence-related self-efficacy independent from the increase in negative 
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affect for example due to depression-specific cognitive biases [44] or learned helplessness 
[45]. Then, we assumed that depressive symptoms would increase the average reported 
intensity of physical withdrawal [8,9,12],  possibly due to an increased internal focus on 
somatic symptoms or difficulties disengaging from physical withdrawal symptoms [44]. 
Finally, we expected that depressive symptoms would have a direct effect on lapse risk as 
well as on smoking frequency at the three month follow-up, for example in rendering 
individuals more vulnerable to social pressure [46]. In order to disentangle the effects of 
depressive symptoms and nicotine dependence, we controlled the analyses for the level of 
nicotine dependence at baseline. 
METHODS 
Participants and procedure 
As described elsewhere [47], participants aged 20-40 years were recruited via mass 
media and the internet in Switzerland. The inclusion criteria were the desire to give up 
smoking within the next month without using smoking cessation methods and the possession 
of an internet-enabled mobile phone. Furthermore, participants reported the average smoking 
frequency during the previous year in a screening question. Only participants were invited to 
take part in study who smoked at least 10 cigarettes per day. After enrolling for the study, 
participants completed an online questionnaire for the baseline measures.  
On the day they started the smoking quit attempt, they were instructed to request the 
EMA questionnaires. Participants were then prompted to complete a short questionnaire at 
three random times throughout the day between 9:00 am and 9:00 pm. The measurements 
took place over a four-week period. A follow-up was conducted three months after the 
beginning of the quit attempt. All participants received a monetary incentive of 100 Swiss 
Francs (around $110) after having filled out the follow-up assessments. The study was 
approved by the local Ethics Committee. 
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A total of 370 interested volunteers filled out the baseline questionnaires and 270 
participated in the EMA study (73%). The overall response rate for the EMA prompts was 
54.7%. A total of 189 participants took part in the three-month follow-up (70% of those who 
took part in the EMA study). Due to the increasing non-compliance with the sampling scheme 
protocol towards the end of the four-week period, we analysed the first 14 days after smoking 
cessation only. Participants with only one or two observations (n = 27) and one multivariate 
outlier were excluded from the analysis.  
Around two-thirds of the remaining participants were men, mean age was 28 years. 
The analysis sample consisted of 7,112 observations (measuring momentary emotional states, 
physical withdrawal symptoms, self-efficacy, urge to smoke and lapses) nested in 242 
participants. The average number of observations per participant was 29 (range 3-45). The 
response rate for all EMA questionnaires for the analysis sample was 69%; an average of 
72.4% completed at least one EMA questionnaire per day (range 97.8% at day one to 60.3% 
at day 13). Forty percent of the participants reported a first lapse on the first day of the quit 
attempt, 66% had lapsed at least once after the sixth day. A description of lapse trajectories 
can be found elsewhere [48]. During the first two weeks of the smoking cessation attempt, the 
average number of days on which participants lapsed was 5.61 (SD = 5.52) per participant. 
More detailed sample characteristics are given in Table 1.  
Insert Table 1 here 
Measures  
At baseline, participants completed an online survey collecting socio-demographic 
information on gender, age, nationality, marital status, and smoking history. Depressive 
symptoms during the previous week were assessed using the German version of The Center 
for Epidemiologic Studies Depression Scale (CES-D) [49]. The questionnaire consists of 20 
items rated on a four-point scale ranging from 0 (‘rarely or none of the time’) to 3 (‘most or 
all of the time’). Nicotine dependence was measured with the German version of The 
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Fagerström Test of Nicotine Dependence (FTND) [50], a six-item self-report scale. At follow-
up three months after the quit attempt, participants reported the frequency of smoking in the 
previous month with the response options 0 = never, 1 = 1-3 times a month, 2 = 1-6 times a 
week, and 3 = daily.  
Using Ecological Momentary Assessment after the beginning of the quit attempt, we 
measured: a) momentary affect, using three items, i.e., ‘feeling content,’ ‘frustrated’ and 
‘tense’ (response categories 1 = not at all to 4 = very much); b) intensity of physical 
withdrawal symptoms (“How severe are your current physical withdrawal symptoms on a 
scale of 0 to 10?”); c) intensity of the urge to smoke (“How intense is your current urge to 
smoke on a scale of 0 to 10?”); d) momentary abstinence-related self-efficacy (“At the present 
time, how confident are you that you succeed in giving up smoking on a scale from 0 to 10); 
and e) the occurrence of lapses since filling out the last questionnaire (0 = no/1 = yes).  
Analysis 
We used Stata 12 for the descriptive statistics of the baseline variables, and Mplus 
7.11 [51] for the multilevel structural equation models. We applied the Diagonally Weighted 
Least Squares (DWLS) estimator with robust standard errors (denoted WLSMV in Mplus), 
which is appropriate for categorical data and provides absolute and comparative fit indices. 
Model fit was assessed through following different indices: the Comparative Fit Index (CFI), 
the Tucker Lewis Index (TLI), and the Root Mean Square Error of Approximation (RMSEA). 
An indication of a good model fit are indices over 0.95 for CFI and TLI [52-54] and 
approaching 0.05 for RMSEA [55]. 
EMA data were not sampled independently; rather, they were nested within the 
participants. Therefore, we fitted the two-level model depicted in Figure 1. The EMA data 
described associations at the situational level (level 1). The variable for lapses was treated as 
binary; the rest of situational variables were treated as continuous scales and were grand-mean 
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centred prior to analyses. To ensure the prospective nature of the analyses, the lapse indicator 
from the subsequent questionnaire (t + 1) was used as outcome of the current situation (t). 
Personal average levels of all situational variables (negative affect, self-efficacy, 
withdrawal symptoms, urge to smoke and occurrence of lapses) were modelled as latent 
variables at the person level (level 2), as represented in Figure 1 by ovals. Person-level 
baseline characteristics, depressive symptoms and nicotine dependence, were introduced to 
explain inter-personal differences in average states across situations [56-58]. Smoking 
frequency at the follow up was included as an outcome variable at the person level.  
RESULTS 
Descriptive statistics for baseline characteristics and the EMA variables are presented 
in Table 1. Three months after the start of the quit attempt, 24% were abstinent and 41% had 
returned to daily smoking. Baseline depressive symptoms were correlated with nicotine 
dependence at baseline (r = .22, p < .001) and predicted frequency of smoking at the three-
month follow-up ( = -.19, p = .007). 
The two-level model 
Intra-class correlations represent the proportion of the total variability in momentary 
states attributable to individual differences compared to situational circumstances. Person- 
level variation was generally smaller for momentary negative affect (.34) than for addiction-
related variables (physical withdrawal symptoms .63; urge to smoke .49; abstinence-related 
self-efficacy .76; lapses .62). The hypothesised two-level model fitted the data well (χ2 = 
23.15, df = 18, p =.18, CFI = .999, TLI = .999, RMSEA = .006). Figure 1 presents the 
standardised path coefficients for this model.  
The situational level pathways 
All the expected associations at the situational level were confirmed (p < .001), apart 
from the direct effect of negative affect on lapse risk ( = -.02, p = .301).  However, due to 
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the very large number of sampled observations (7,112), statistical significance of even very 
small effects was expected. We therefore emphasise the effect sizes of estimated paths.  
As expected, momentary negative affect was associated with a lower abstinence-
related self-efficacy ( = -.12) and higher urge levels ( = .20). However, the urge to smoke 
was better predicted by physical withdrawal symptoms ( = .46) than by negative affect. 
Finally, higher subsequent lapse risk was predicted by the direct effect of decreased self-
efficacy and the influence of increased urge to smoke, both direct ( = .09) and indirect 
through reduced self-efficacy (path from urge to smoke to self-efficacy  = -.20; path from 
self-efficacy to lapses  = -.11).  
The effect of baseline depressive symptoms on a person’s average states and smoking 
cessation outcomes 
At the person level (N= 242), most relationships were significant at the p < .001 level. 
In what follows, the p < .001 significance level is assumed unless otherwise stated. 
Depressive symptoms at baseline were associated with a higher personal average of negative 
affect (  = .35) but not physical withdrawal symptoms (  = .11; p = .058) during the first 
two weeks of an unassisted smoking cessation attempt. Furthermore, the situational level 
pathways were confirmed as more stable patterns relating to individual differences. 
Specifically, the person’s average negative affect was associated with a lower average self-
efficacy (  = -.31) and higher urge levels (  = .19). Even to a greater extent than at the 
situational level, the average urge to smoke was predicted by average withdrawal symptoms 
(  = .75). Higher occurrence of lapses was predicted by higher average urge to smoke (  = 
.32) as well as reduced self-efficacy (  = -.42). It can be seen that the person’s average states 
are highly predictive of the number of lapses; much more so than momentary states are 
predictive of situation-specific lapses.  
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Finally, the number of lapses during the first two weeks of the quit attempt was the 
only direct predictor of  frequency of smoking in the three-month follow-up ( = .54). 
Baseline depressive symptoms and average states influenced the frequency of smoking at the 
follow up indirectly, through the occurrence of lapses. The hypothesised direct effects of 
baseline depressive symptoms on average self-efficacy ( = -.09, p = .096), the urge to smoke 
( = -.02, p = .607), number of lapses (  = .07, p = .260) and smoking frequency at the three-
month follow-up (  = .02, p = .761) were not confirmed. 
DISCUSSION   
This study aimed at providing a better understanding through which mechanisms 
negative affect at the situational level and depressive symptoms as more enduring person 
characteristics increased lapse risk during the first two weeks of an unassisted smoking 
cessation attempt. At the situational level, negative affect predicted lower abstinence-related 
self-efficacy and elevated urge levels, which in turn were direct antecedents of subsequent 
lapses. At the person level, these situational level pathways were confirmed as more stable 
patterns. While the associations at the level of situation-specific lapses were mainly weak, a 
person’s average states were highly predictive of the frequency of lapses during the first two 
weeks of the quit attempt. Specifically the associations between negative affect and 
abstinence-related self-efficacy, self-efficacy and frequency of lapses as well as urge to smoke 
and lapses were stronger at the person level. Depressive symptoms at baseline, controlling for 
the effects of nicotine dependence, were strongly associated with higher average negative 
affect experienced by a person during the quit attempt. However, we did not find direct effects 
of depressive symptoms on average self-efficacy, urge to smoke, the frequency of lapses, and 
smoking frequency at follow-up.  
Overall, our results corroborate previous evidence that on the situational level, 
negative affect, lower self-efficacy, higher levels of withdrawal symptoms, and higher levels 
of the urge to smoke directly or indirectly contribute to a higher lapse risk. Additionally, our 
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ecological momentary assessment study elucidated associations between these states. 
Negative affect was associated with decreased self-efficacy and increased urge to smoke. 
Thus, negative affect seemed to undermine one’s confidence in being able to remain abstinent 
directly as well as indirectly via an increased urge. Both pathways might stimulate 
motivational and decisional processes leading to lapses [30-34]. Negative affect and 
withdrawal were only indirectly associated with lapse risk via decreased self-efficacy and 
increased urge to smoke. Against our hypothesis, momentary negative affect did not have an 
additional direct association with subsequent lapse risk. Therefore, our findings did not 
support models which assume that negative affect directly triggers a lapse or operates as 
conditioned stimulus that elicits a conditioned response. This concurs with some previous 
EMA studies [22,23,59], which did not find an effect of negative affect when taking levels of 
craving into account. One explanation is that negative affect is too volatile to predict 
subsequent lapses that in our design may occur hours later or even the next day [22]. 
At the person level, our results suggest that the link between baseline depressive 
symptoms and less favourable smoking cessation outcomes was mediated by higher 
situational negative affect. As negative affect is a main characteristic of depression [43], we 
expected a strong effect on situational negative affect during the smoking cessation attempt. 
More surprising was the lack of a direct effect of depressive symptoms on abstinence-related 
self-efficacy, which was only indirectly influenced via negative affect. However, the 
association between depression and self-efficacy [61] must be qualified in the context of an 
unassisted smoking cessation attempt. One prerequisite of an unassisted quit attempt is a 
certain degree of abstinence-related self-efficacy, which might be more robust than in 
individuals who do not try to quit smoking at all or undergo a smoking cessation intervention. 
However, situational negative affect in self-quitters might compromise otherwise robust 
abstinence-related self-efficacy. Also in contrast to other studies [8,9,12], our findings did not 
11 
 
support an association between baseline depressive symptoms and elevated physical 
withdrawal symptoms or higher urge levels when controlling for nicotine dependence.  
In summary, our results suggested that the path linking baseline depressive symptoms 
and smoking cessation outcomes was mediated by increased negative affect experienced by a 
person during the quit attempt, which in turn decreased situational abstinence-related self-
efficacy and increased the urge to smoke. Thus, baseline depressive symptoms, controlled for 
nicotine dependence, seemed to have more impact on affective than on cognitive or 
behavioural antecedents of lapses during the smoking cessation attempt.  
Some limitations of this study must be kept in mind.  EMA assesses real experiences 
in a given context at a particular time better than self-report questionnaires, which measure 
rather subjective mental representations of experiences. Therefore, EMA data are less prone 
to memory or cognitive judgment biases [51,62]. This is important as there is evidence for 
biased memory processes for emotional material, overly general autobiographical memory, 
and increased elaboration of negative information in depressed individuals [44]. A drawback 
of our EMA approach is that filling out the ecological momentary assessments three times a 
day may have increased self-monitoring and affected the associations of the antecedents of 
lapses and lapse risk in high-risk situations. Furthermore, in order not to be too disruptive we 
limited the number of EMA items. Thus, the intensity of physical withdrawal symptoms and 
abstinence-related self-efficacy were assessed with a one-item question instead of a more 
comprehensive measure.  
Moreover, we assessed negative affect, self-efficacy, withdrawal symptoms, and the 
urge to smoke for the same timeframe. Therefore, we could not establish the temporal 
associations between these variables. Lapses as outcomes were used from the subsequent 
EMA assessment, which was not necessarily from the same day. Although there is a 
longitudinal sequence in the assessment of baseline characteristics, EMA items, subsequent 
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lapses, and the smoking frequency at follow-up, the results can only be interpreted in terms of 
predictive but not causal relationships. 
Some sample characteristics may limit generalisability of the results. This study 
included a self-selected sample in which participants were prepared to undergo intensive data 
collection. The extensive EMA over 30 days may be a reason for the relatively low response 
rate of 55%. Men were overrepresented in our sample, average age of the participants was 
relatively low and the level of nicotine dependence was low to moderate. One explanation for 
the lacking direct effects of baseline depressive symptoms may be that our sample consisted 
of self-quitters with an average level of low to moderate nicotine dependence and non-clinical 
depressive symptoms. Therefore, our results have to be replicated in other samples with 
participants with higher nicotine dependence. Furthermore, we measured depressive 
symptoms retrospectively at baseline within a one-week window and did not ascertain how 
long they had persisted before the start of the study. Thus, we cannot differentiate between 
depressive symptoms that were associated with the anticipation of the quit attempt and a 
depressive disorder or personality trait. Furthermore, we could not verify self-report data on 
smoking biochemically. 
Conclusions: Negative affect was associated with decreased self-efficacy and 
increased urge to smoke, which in turn increased lapse risk at the situation level. Depressive 
symptoms at the baseline, controlling for the effects of nicotine dependence, were strongly 
associated with higher average negative affect experienced by a person during the smoking 
cessation attempt. This was the only pathway through which depressive symptoms influenced 
lapse risk and a higher smoking frequency three months after the smoking cessation attempt. 
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Table 1  
Descriptive Statistics for the Baseline Characteristics, the EMA Outcomes and the Frequency 
of Smoking at the Three-Month Follow-up  
 Mean or % SD 
Baseline characteristics (N = 242) 
Male sex 66.94%  
Not married 83.00% -- 
Age 28.16 5.50 
Swiss Nationality 91.49% -- 
Age of smoking onset  16.89 2.87 
Cigarettes per day  
-  between 11 and 20 







Depressive symptoms (CES-D total score)  14.44 9.14 
Nicotine dependence (FTND total score) 3.86 1.88 
Experience sampling observations (N=7,112) 
Negative affect (3-12) 5.47 1.70 
Withdrawal symptoms (0-10) 3.46 0.15 
Urge to smoke (0-10) 4.64 1.14 
Self-efficacy (0-10) 6.56 1.14 
Lapses 
a
 24.83% -- 
Frequency of smoking in the previous month at follow-up (N = 173) 
Never 
1-3 times a month 









Daily 41.04% -- 
Note: 
a
 percentage of participants reporting lapses; * p < .05, ** p < .01, *** p < .001 
0 
 
Figure 1: Two-level model of momentary and distal effects of depressive symptoms and nicotine dependence on lapse risk, with standardised 
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